Twist Bioscience CorporationNASDAQ: TWST

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

· Issued by Twist Bioscience Corporation via Business Wire

Summary by 6ix AI

Twist Bioscience Corporation said it will grant a total of 17,681 restricted stock units (rights to receive company shares over time) to 19 recently hired individuals, as an inducement material to their accepting employment with Twist.

Key details

  • The awards will be granted under Twist's Amended and Restated Inducement Equity Incentive Plan, in line with Nasdaq Listing Rule 5635(c)(4). The plan is used only for awards to people who were not previously Twist employees, or who return after a bona fide period of non-employment.
  • For some of the units, 25% vest on the one-year anniversary of the vesting commencement date and 1/16 vest on each quarterly anniversary after that, over 48 months in total.
  • For other units, 1/16 vest on each quarterly anniversary of the vesting commencement date, over 48 months.
  • Grants of less than 100 shares vest 1/8 on each biannual anniversary, and grants of less than 50 shares vest 1/4 on each annual anniversary, both over a total of 48 months.

What’s still pending

  • Vesting of the units is subject to each employee's continued service through each vesting date.

6ix AI wrote this summary from the release below and checked it against the release.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value healthcare company, today announced that a total of 17,681 restricted stock units (“RSUs”) will be granted to 19 recently hired individuals, in each case as an inducement material to their acceptance of employment with Twist. The employment inducement awards will be granted under Twist’s Amended and Restated Inducement Equity Incentive Plan and related form of restricted stock unit award agreement in accordance with Nasdaq Listing Rule 5635(c)(4).

The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Twist, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with Twist, pursuant to Nasdaq Listing Rule 5635(c)(4).

A portion of the 17,681 RSUs vest over a 48-month period for each employee as follows: 25% vests on the one-year anniversary of the applicable vesting commencement date (the “Vesting Commencement Date”), and 1/16 of the RSUs vest on each quarterly anniversary (or the last day of the month if no such day exists) of the Vesting Commencement Date thereafter, subject to the employee’s continued service through each vesting date. A portion of the 17,681 RSUs vest over a 48-month period for each employee as follows: 1/16 of the RSUs vest on each quarterly anniversary (or the last day of the month if no such day exists) of the Vesting Commencement Date, subject to the employee’s continued service through each vesting date. Notwithstanding the above, if the RSU grant is less than 100 shares, 1/8 of the RSUs vest on each biannual anniversary (or the last day of the month if no such day exists) of the Vesting Commencement Date for a total vesting period of 48 months; or if the RSU grant is less than 50 shares, 1/4 of the RSUs vest on each annual anniversary (or the last day of the month if no such day exists) of the Vesting Commencement Date for a total vesting period of 48 months.

About Twist Bioscience Corporation

At Twist Bioscience, our customizable solutions across the biological continuum raise the bar in diagnostics, therapeutics, industrial, agriculture and research markets.

We drive innovation with confidence, without compromise. Whether delivering oligos, genes, proteins, libraries, characterization data, antibody discovery solutions, or NGS workflow tools, our scientific expertise and exceptional customer experience help navigate complex challenges, all with precision and at the scale and speed customers require. By enhancing R&D efficiency at every turn, we give scientists more shots on goal – more experiments, more iterations, more chances for remarkable discoveries.

Together, we stand with customers in the relentless pursuit of progress, backed by enterprise reliability, to shape a healthier and more sustainable future for all. For more information about our products and services, please visit www.twistbioscience.com.

Follow us on LinkedIn | X | YouTube | Instagram | Bluesky

View original source (Business Wire)Twist Bioscience Corporation on 6ix

Story so far

Earlier from Twist Bioscience

Later from Twist Bioscience

All Twist Bioscience news releases